Фармакоэкономический анализ применения лекарственных средств первой и второй линии в лечении рассеянного склероза

@article{2015,
  title={Фармакоэкономический анализ применения лекарственных средств первой и второй линии в лечении рассеянного склероза},
  author={В. Р. Мкртчян and Л. В. Брылев and О. В. Давыдова and Алексей Владимирович Белянин and И. А. Шпак and Александр Михайлович Сергеев},
  journal={Neurology, neuropsychiatry, Psychosomatics},
  year={2015},
  volume={7},
  pages={35-39}
}
Objective: to make a pharmacoeconomic comparison of the administration of first- and second-line drugs in the treatment of multiple sclerosis through cost, cost-effectiveness, and budget impact analyses using the 2015 state prices. Material and methods. A pharmacoeconomic analysis was carried out on the basis of the data available in the literature on trials of the effects of the drugs on the rates of exacerbations and disability. On calculating, the authors took into account the current… 
2 Citations
Современное состояние системы здравоохранения Российской Федерации
TLDR
The article presents the methodological foundations of a health and offers a solution to the problem through the development of tools for monitoring and evaluation of health services.
Modelling expenses for multiple sclerosis treatment
Modern theory of multiple sclerosis requires substantial state expenditures which needs thorough clinical and economic implications assessment of introducing novel drugs in this disease treatment.